CAS: 1257293-83-6 - 1-(3-Azetidinyl)-4,4-difluoropiperidine
Formula:C8H14F2N2
InChI:InChI=1S/C8H14F2N2/c9-8(10)1-3-12(4-2-8)7-5-11-6-7/h7,11H,1-6H2
InChI key:InChIKey=OIQJXEUDXZJIRR-UHFFFAOYSA-N
SMILES:FC1(F)CCN(CC1)C2CNC2
- Synonyms:
- 1-(Azetidin-3-yl)-4,4-difluoropiperidine
- 1-(3-Azetidinyl)-4,4-difluoropiperidine
- Piperidine, 1-(3-azetidinyl)-4,4-difluoro-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
1-(azetidin-3-yl)-4,4-difluoropiperidine REF: IN-DA000OK9CAS: 1257293-83-6 | - - - | To inquire | Thu 21 Nov 24 | |
1-(Azetidin-3-yl)-4,4-difluoropiperidine REF: 54-PC400503CAS: 1257293-83-6 | - - - | To inquire | Fri 29 Nov 24 | |
1-(Azetidin-3-yl)-4,4-difluoropiperidine REF: 10-F462214CAS: 1257293-83-6 | 95.0% | - - - | Discontinued product | |
1-(Azetidin-3-yl)-4,4-difluoropiperidine REF: 3D-HAC29383CAS: 1257293-83-6 | Min. 95% | - - - | Discontinued product |
1-(azetidin-3-yl)-4,4-difluoropiperidine
CAS:1257293-83-6
Formula:
C8H14F2N2
Color and Shape:
Solid
Molecular weight:
176.2070
Ref: IN-DA000OK9
Undefined size | To inquire |
Estimated delivery in United States, on Thursday 21 Nov 2024
1-(Azetidin-3-yl)-4,4-difluoropiperidine
CAS:1257293-83-6
Color and Shape:
Powder
Molecular weight:
176.21g/mol
Ref: 54-PC400503
Undefined size | To inquire |
Estimated delivery in United States, on Friday 29 Nov 2024
1-(Azetidin-3-yl)-4,4-difluoropiperidine
CAS:1257293-83-6
Purity:
95.0%
Molecular weight:
176.21099853515625
Ref: 10-F462214
1g | Discontinued | Request information | |
250mg | Discontinued | Request information |
1-(Azetidin-3-yl)-4,4-difluoropiperidine
CAS:1257293-83-6
1-(Azetidin-3-yl)-4,4-difluoropiperidine is a chemical intermediate that can be used in the synthesis of other compounds. …
Formula:
C8H14F2N2
Purity:
Min. 95%
Molecular weight:
176.21 g/mol
Ref: 3D-HAC29383
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |